The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Deep dive case study of antitrust claims surrounding pharmaceutical drug pricing and practices. Explore the valuation of unsecured claim in a bankruptcy setting. Address the difference between claim estimation and damage calculation. Discuss the difference between private and government insurance claims.
Learning Objectives:
Identify the nature of litigation claim estimation in a bankruptcy setting
Distinguish the different payor participants for pharmaceuticals
Differentiate between claim estimation and damage calculations.